Skip to main content

What the FDA labels say about taking them together

Cannabidiol and clopidogrel

Cannabidiol's FDA label of May 29, 2026 names clopidogrel in its drug interactions section; the clopidogrel label PlainMeds reads does not name cannabidiol. The cannabidiol label: “For CYP2C19 substrates (e.g., clopidogrel) where efficacy is mainly due to their active metabolite (s), concomitant use of EPIDIOLEX may decrease plasma concentration of the active metabolite (s) and may therefore …”

Check it at the source: the cannabidiol FDA label on DailyMed (effective May 29, 2026, Jazz Pharmaceuticals, Inc.); the clopidogrel FDA label on DailyMed (effective May 30, 2025, Sanofi-Aventis U.S. LLC).

What does the cannabidiol label say about clopidogrel?

Cannabidiol label, drug interactions

For CYP2C19 substrates (e.g., clopidogrel) where efficacy is mainly due to their active metabolite (s), concomitant use of EPIDIOLEX may decrease plasma concentration of the active metabolite (s) and may therefore decrease efficacy.

Source: FDA drug label (Epidiolex), Jazz Pharmaceuticals, Inc., effective May 29, 2026 (SPL set 8bf27097-4870-43fb-94f0-f3d0871d1eec), via openFDA; the full label on DailyMed

What does the clopidogrel label say about cannabidiol?

Clopidogrel's label (effective May 30, 2025) does not name cannabidiol in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Plavix), Sanofi-Aventis U.S. LLC, effective May 30, 2025 (SPL set de8b0b67-eb25-4684-83b5-7ad785314227), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

0Cannabidiol generic labelers
35Clopidogrel generic labelers
CannabidiolClopidogrel
Labeled forn/aHeart attack and coronary artery disease, Angina
Boxed warningNoYes
Pharmacy cost (NADAC)n/a$0.0472 per tablet 75 mg tablet
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?